Clinical Trials Directory

Trials / Completed

CompletedNCT04749017

The Potential Effect of Avena Sativa L. on Wellness/Wellbeing During Smoking Reduction/Cessation Experience

A Double Blind, Randomized, Controlled Study for the Potential Effect of Avena Sativa L. on Wellness/Wellbeing During Smoking Reduction/Cessation Experience

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
140 (actual)
Sponsor
Universidad Católica San Antonio de Murcia · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the potential effect of Avena Sativa L. on wellbeing during smoking reduction/cessation

Detailed description

The duration of the study will be 90 days (12 weeks). The consumption time will be set at 60 days (8 weeks), the remaining 30 days will be for follow up, the product will not be consumed. Each day of the study will be recorded in a diary by each subject. Subjects are randomized based on the number of cigarettes and the Richmond test. In addition, subjects with a high score on the DASS-21 test items could not participate in the study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTExperimental product consumptionConsumption of the experimental product 2 capsules daily, morning and evening (450 mg each capsule) for 60 days
OTHERControl product consumptionConsumption of control product of identical appearance 2 capsules daily for 60 days, morning and evening

Timeline

Start date
2021-01-20
Primary completion
2021-07-30
Completion
2021-12-31
First posted
2021-02-10
Last updated
2022-02-15

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04749017. Inclusion in this directory is not an endorsement.